Alumni Ventures | Activity

Investment

Participated in Andromeda Surgical's $15M Series A for AI-powered autonomous surgical robotics.

Andromeda Surgical

Andromeda Surgical Alumni Ventures

svpost.comAUG 4, 2026

AUG 4, 2026

Essay

Essay on how a Strait of Hormuz disruption would ripple beyond gasoline prices into plastics, pharma, and aviation-fuel feedstocks.

Distilling Oil: The Unseen Cost of the Strait Closure

Alumni Ventures

av.vcJUL 27, 2026

JUL 27, 2026

Essay

Essay arguing that as AI automates digital work, companies are investing more in in-person experiences to build trust with high-value clients.

AI Scales Work. Trust Scales in Person.

Alumni Ventures

av.vcJUL 21, 2026

JUL 21, 2026

Essay

Essay on U.S. defense manufacturing's tacit-knowledge crisis as skilled workers retire, arguing for full-stack manufacturers that embed factory-floor data collection.

The Ghost in the Machine

Alumni Ventures

av.vcJUL 15, 2026

JUL 15, 2026

Investment

Participated in Katalyze AI's $10.5M seed round for agentic AI in pharmaceutical manufacturing.

Katalyze AI

Katalyze AI Alumni Ventures

finsmes.comJUL 13, 2026

JUL 13, 2026

Investment

Backed Japanese neutral-atom quantum computing startup Yaqumo in Alumni Ventures' first Japan investment.

Yaqumo

Yaqumo Alumni Ventures

thequantuminsider.comJUN 12, 2026

JUN 12, 2026

Investment

Participated in BeatpulseLabs' $1.8M pre-seed round for enterprise AI training-data infrastructure.

BeatpulseLabs

BeatpulseLabs Alumni Ventures

tech.euJUN 8, 2026

JUN 8, 2026

New Fund

Launched the Global Bridge Fund Series with new London and Tokyo offices, including a Japan-U.S. Bridge Fund built on partnerships with KDDI and UTokyo Innovation Platform.

Global Bridge Fund Series (London + Tokyo)

Alumni Ventures

av.vcJUN 8, 2026 av.vc

JUN 8, 2026

Investment

Continued as a participating investor in Century Health's oversubscribed $5M seed round for its AI clinical-data abstraction platform.

Century Health

Century HealthAlumni Ventures

prnewswire.comMAY 19, 2026

MAY 19, 2026

News

Named #20 out of 350 in TIME Magazine's America's Top Venture Firms, reflecting top-decile investment performance.

TIME Magazine Top 20 VC Firms Award

Alumni Ventures

av.vc

Added recently

Essay

Published analysis on how venture deals are assessed and investment returns tracked, emphasizing valuation context.

Startup Valuation and Venture Returns

Alumni Ventures

av.vcAPR 30, 2026

APR 30, 2026

Essay

Published essay exploring exit mechanisms including IPOs, M&A, and liquidation strategies in venture capital.

How Venture Investments Exit

Alumni Ventures

av.vcAPR 30, 2026

APR 30, 2026

Essay

Published insights on VC funding priorities targeting founders solving mission-critical problems in fintech, space tech, and emerging sectors.

VC in 33: What Kinds of Startups Do VCs Want to Fund?

Alumni Ventures

av.vcAPR 29, 2026

APR 29, 2026

Essay

Analyzed blockchain and digital asset opportunities as maturing infrastructure for scalable, utility-driven financial systems.

The Next Financial System Is Being Built Right Now

Alumni Ventures

av.vcAPR 24, 2026

APR 24, 2026

Alumni Ventures Activity

Participated in Andromeda Surgical's $15M Series A for AI-powered autonomous surgical robotics.

Essay on how a Strait of Hormuz disruption would ripple beyond gasoline prices into plastics, pharma, and aviation-fuel feedstocks.

Essay arguing that as AI automates digital work, companies are investing more in in-person experiences to build trust with high-value clients.

Essay on U.S. defense manufacturing's tacit-knowledge crisis as skilled workers retire, arguing for full-stack manufacturers that embed factory-floor data collection.

Participated in Katalyze AI's $10.5M seed round for agentic AI in pharmaceutical manufacturing.

Backed Japanese neutral-atom quantum computing startup Yaqumo in Alumni Ventures' first Japan investment.

Participated in BeatpulseLabs' $1.8M pre-seed round for enterprise AI training-data infrastructure.

Launched the Global Bridge Fund Series with new London and Tokyo offices, including a Japan-U.S. Bridge Fund built on partnerships with KDDI and UTokyo Innovation Platform.

Continued as a participating investor in Century Health's oversubscribed $5M seed round for its AI clinical-data abstraction platform.

Named #20 out of 350 in TIME Magazine's America's Top Venture Firms, reflecting top-decile investment performance.

Published analysis on how venture deals are assessed and investment returns tracked, emphasizing valuation context.

Published essay exploring exit mechanisms including IPOs, M&A, and liquidation strategies in venture capital.

Published insights on VC funding priorities targeting founders solving mission-critical problems in fintech, space tech, and emerging sectors.

Analyzed blockchain and digital asset opportunities as maturing infrastructure for scalable, utility-driven financial systems.